Table 1.
Patient characteristics, junctional ectopic tachycardia features, and drug treatment
| Patient | Sex | JET onset | Heart rate at presentation (bpm) | Heart rate at discharge (bpm) | Familiarity | Heart failure | Decreased SF/EF | Treatment | Follow up |
| 1 | F | 6 months | 190 | 100 | – | – | + | DG + PF | 14.6 years |
| 2 | F | 4 months | 170 | 110 | – | – | – | PF | 7.1 years |
| 3 | F | 6 months | 240 | 170 | + | + | + | DG+AM | 12.5 years |
| 4 | F | 2 months | 170 | 120 | + | – | – | AM+PF | 8.2 years |
| 5 | M | 5 months | 170 | 110 | – | – | – | PF | 21.5 years |
| 6 | F | 3 months | 300 | 130 | + | + | + | DG+AM+PF | 18.8 years |
| 7 | M | 2 months | 270 | 130 | + | + | + | DG+AM+PF | 16.5 years |
| 8 | F | 1 month | 240 | 140 | – | – | + | DG+AM+FL | 2.6 years |
| 9 | F | 6 months | 300 | 120 | + | + | + | DG+AM+FL | 10.5 years |
AM, amiodarone; DG, digoxin; EF, ejection fraction; FL, flecainide; JET, junctional ectopic tachycardia; PF, propafenone; SF, shortening fraction.